In fact, a range of complementary elements have already been developed and delivered on The Forge..
The initial requirement was to design and build a pharmaceutical facility in 15 months that would usually have taken closer to three years to complete, in order to maintain supply of a life-saving treatment for people with HIV.We achieved this mould-breaking pharmaceutical facility by, as described, investing significant time and focus in modelling the problem before going anywhere near construction..
The Parma project is an evidenced demonstration that our Design to Value approach made it possible to design, construct and commission a new pharmaceutical manufacturing facility in record time without increasing budgets or compromising on any aspect of quality.. A proven approach: shaping the future of construction with DtV.At Bryden Wood, we do not come to a project with a ready-made solution.We bring only our Design to Value approach, using the combined powers of data, construction technology and imagination to establish what the most effective solution will be.. We have been working this way for over 25 years.
, delivering major design and construction projects in pharmaceutical and process facilities, data centres, aviation, healthcare, education, residential, water infrastructure, transport infrastructure, custodial facilities… It has unlimited applications.. Our Design to Value approach is proven to deliver better results for the built environment, and for our clients..It is being done.. To learn more about our Design to Value philosophy, read Design to Value: The architecture of holistic design and creative technology by Mark Bryden, John Dyson, Jaimie Johnston MBE and Martin Wood.
Available to purchase at.Adam Jordan, Asia-Pacific lead at Bryden Wood, reviews developments in Design for Manufacture and Assembly (DfMA), construction platforms (P-DfMA) and Modern Methods of Construction (MMC) in Asian markets.. Bryden Wood is focused on developing innovative approaches to improve the efficiency and productivity of the construction industry.
We were pioneers in Design for Manufacture and Assembly (DfMA) before the approach even had a name.team in July 2014, having previously worked in architectural firms in Spain, and after graduating from San Pablo CEU University in Spain in 2013..
Her experience includes public and urban spaces, residential development as well as sustainability and landscape projects.During her start at Bryden Wood, Cristina was involved in the design and feasibility study of a pharmaceutical project in Nigeria for GlaxoSmithKline.
Working as part of a team her key focus was to coordinate the cross discipline information to clarify the best options to take forward into design.After that, she collaborated in the design and development of residential plots in Sugar House Island.. Having gathered experience in a variety of sectors, Cristina is currently the architect for the Front End Factory GSK Project, working with information of a sensitive nature.